Cedars-Sinai Medical Center

medical staff pulse newsletter

Text size: A A A
A BI-WEEKLY PUBLICATION FROM THE CEDARS-SINAI CHIEF OF STAFF May 11, 2012 Issue | Archived Issues

New FDA alerts

Pharmacy focus

The U.S. Food and Drug Administration issued updates and warnings for phenytoin, fosphenytoin, dronedarone, aliskiren and other drugs.

» Read more


Physician news

David Rimoin, MD, PhD, named an American College of Physicians master, Ilana Cass, MD, selected for the Executive Leadership in Academic Medicine fellowship, a Kawasaki disease study by Moshe Arditi, MD, honored at conference, and Robert H. Baloh, MD, PhD, received ALS Association award.

» Read more


Meetings and events


Grand rounds

Click here to view upcoming Grand Rounds.


Upcoming CME conferences

Click below to view a complete list of all scheduled Continuing Medical Education conferences.

CME Newsletter - May 2012 (PDF)

Share Your News

Won any awards or had an article accepted for publication? Share your news about professional achievements and other items of interest.

Click here to share your news

PATHway to success

Flawless state inspection for Department of Pathology and Laboratory Medicine

The Department of Pathology and Laboratory Medicine lived up to its motto of "Always ready, all the time," when a recent state inspection found its facilities and procedures meet the highest standards.

Besides accreditation by the College of American Pathologists, the department must ensure it meets all federal and California laws and regulations. An April 17 visit from a state Department of Public Health Laboratory Field Services examiner found zero deficiencies in Cedars-Sinai’s compliance with California clinical laboratory laws and regulations.

"During our inspection, we were commended for the quality of our operation and the size and scope of our testing," said Mahul Amin, MD, chair of the Department of Pathology and Laboratory Medicine. "The success of this inspection is a reflection of the dedication every member of our department to quality patient care and daily commitment to holding our laboratories to the highest professional standards."

The examiner added in her summation that she could "tell this is a great place to work."

For the Pathology and Laboratory Medicine department, this successful inspection is just another step on what its PATHway - the name the department has given its formal quality and compliance management programs.

These programs provide a quality commitment to every patient and physician using the department's clinical laboratories that "every life deserves a quality laboratory test or opinion at the speed of right." The PATHway goal is to proactively address accreditation and regulatory requirements and to engage the leadership and staff members of each laboratory section.

PATHway also is a guiding force in the College of American Pathology Interim Self-Inspection, required to maintain this key accreditation. The self-inspection offers an opportunity to identify more improvements to maximize efficiency, accuracy and best practices throughout the department’s operations.

"Our internal inspectors strive very hard to identify possible deficiencies, and every section takes these findings very seriously," Amin said. "By continually challenging itself to improve, our staff ensures that we are always providing the most advanced and best care available."